Loading organizations...
§ Private Profile · Box 112 23 King Street, Cambridge CB1 1AH, Great Britain
Regulatory Genome is a technology company.
Regulatory Genome provides structured, machine-readable regulatory data, transforming fragmented and often complex global regulations into a digital format. The company’s platform acts as a critical data layer between regulatory authorities and solution providers, delivering AI-optimized datasets, control and obligations libraries, and policy intelligence suites. This enables faster signal detection, reliable change tracking, and audit-ready outputs for enhanced compliance, risk assessment, and regulatory workflows.
The company emerged from research at the University of Cambridge, established as a founding member of the Regulatory Genome Project. This origin highlights an insight into the growing chasm between rapidly evolving regulation and the lagging capacity of existing data solutions to keep pace. Its academic foundation underscores a commitment to rigorous information structures and data provenance.
Regulatory Genome serves a diverse clientele including RegTech firms, providers of risk and controls solutions, and regulatory bodies themselves. Its vision centers on becoming the fundamental data backbone of the regulatory ecosystem, empowering next-generation compliance tools and supervisory capabilities. The company aims to align regulatory publishing with modern digitization and artificial intelligence, fostering a more transparent and efficient global regulatory landscape.
Regulatory Genome has raised $6.0M across 1 funding round.
Regulatory Genome has raised $6.0M in total across 1 funding round.
Regulatory Genome (also known as RegGenome or Regulatory Genome Development) is a Cambridge, UK-based technology company that builds a GenAI-optimized platform providing machine-readable regulatory data. It aggregates, classifies, and structures complex, unstructured regulations—primarily in financial and environmental sectors—into a universal, actionable format, enabling organizations to automate compliance workflows, reduce costs, and enhance regulatory intelligence.[1][2][3][4][5]
The platform serves compliance leaders, regulatory affairs professionals, legal teams, and technology officers facing challenges from the growing volume and complexity of regulations across jurisdictions. By leveraging AI, deep learning, and expert-reviewed structures (anchored to the University of Cambridge's Regulatory Genome Project), it solves manual, labor-intensive compliance processes, offering features like LLM-optimized data, flexible integrations, ethical data provenance, analytics for benchmarking, and curated datasets.[1][2]
Regulatory Genome emerged from the Regulatory Genome Project (RGP), a research initiative at the University of Cambridge's Judge Business School and Cambridge Centre for Alternative Finance (CCAF). The RGP began in early 2020, building on a 2018 pilot software tool that provided fintech firms with insights into regulatory obligations across countries; by 2019, it expanded to support regulatory bodies in policy benchmarking.[2]
The company's technology stems from the Cambridge Regulatory Genome (CRG), an open information structure developed collaboratively to organize and compare regulatory obligations, addressing financial regulation's increasing intricacy from diversified markets and jurisdictions. Regulatory Genome Development commercialized this academic foundation, combining regulatory expertise with large-scale machine learning to structure global financial and environmental regulations, achieving over $6M in funding and establishing operations in Cambridge, UK.[1][2][4]
Regulatory Genome rides the regulatory tech (RegTech) wave, fueled by exploding compliance demands from fragmented global regulations, fintech innovation, and AI-driven automation needs. Its timing aligns with post-2020 shifts in socio-political landscapes and technology, where traditional manual processes fail amid diversified financial products and jurisdictions—exacerbated by environmental regs and AI tools like LLMs requiring structured data.[2][3]
Market forces favoring it include rising compliance costs, regulatory benchmarking needs for policymakers, and the push for scalable intelligence in fintech and beyond; by powering "smarter tools and scalable regulatory systems," it influences the ecosystem as the "trusted data layer," enabling innovation while dismantling barriers via open structures like CRG.[1][2][3]
Regulatory Genome is poised to expand its data repository beyond finance and environment into broader sectors, capitalizing on GenAI advancements for deeper LLM integrations and real-time updates. Trends like AI governance, global harmonization efforts, and ESG reporting will propel demand, potentially scaling its $6M+ funding into enterprise dominance.[1]
As RegTech matures, its Cambridge-rooted expertise could evolve influence from data provider to ecosystem enabler, fostering policy innovation and automated compliance at global scale—transforming regulatory chaos into a structured genome for the AI era.[2][3]
Regulatory Genome has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in April 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2022 | $6M Seed | Evolution Equity Partners | Cisco Investments, Passion Capital, Albionvc, Marcio Siqueira, Mastercard | Announced |
Regulatory Genome has raised $6.0M in total across 1 funding round.
Regulatory Genome's investors include Evolution Equity Partners, Cisco Investments, Passion Capital, AlbionVC, Marcio Siqueira, Mastercard.